Abstract
Methionine sulfoxide is a common posttranslational oxidative modification that can alter protein function. Vulnerability of specific proteins to methionine oxidation varies and depends on their structure. In the current study, detection of methionine sulfoxide in intact proteins is mediated by novel anti-methionine sulfoxide antibody that resulted in the identification of three major methionine sulfoxide–proteins in brain: bisphosphate aldolase A and C, α and β subunits of hemoglobin, and serum albumin. The locations of the methionine sulfoxide residues were determined by massspectrometry analyses. It is suggested that the in vivo methionine oxidation of these proteins represent early posttranslational oxidative modification of proteins in brain. Thus, elevated levels of methionine-sulfoxide in these proteins may serve as bio-markers for enhanced oxidative stress in brain, which may be associated with brain disorders and diseases.
Keywords: Aldolase, hemoglobin, oxidative stress, posttranslational modifications, protein oxidation, serum albumin.
Protein & Peptide Letters
Title:Detection and Localization of Methionine Sulfoxide Residues of Specific Proteins in Brain Tissue
Volume: 21 Issue: 1
Author(s): Jackob Moskovitz
Affiliation:
Keywords: Aldolase, hemoglobin, oxidative stress, posttranslational modifications, protein oxidation, serum albumin.
Abstract: Methionine sulfoxide is a common posttranslational oxidative modification that can alter protein function. Vulnerability of specific proteins to methionine oxidation varies and depends on their structure. In the current study, detection of methionine sulfoxide in intact proteins is mediated by novel anti-methionine sulfoxide antibody that resulted in the identification of three major methionine sulfoxide–proteins in brain: bisphosphate aldolase A and C, α and β subunits of hemoglobin, and serum albumin. The locations of the methionine sulfoxide residues were determined by massspectrometry analyses. It is suggested that the in vivo methionine oxidation of these proteins represent early posttranslational oxidative modification of proteins in brain. Thus, elevated levels of methionine-sulfoxide in these proteins may serve as bio-markers for enhanced oxidative stress in brain, which may be associated with brain disorders and diseases.
Export Options
About this article
Cite this article as:
Moskovitz Jackob, Detection and Localization of Methionine Sulfoxide Residues of Specific Proteins in Brain Tissue, Protein & Peptide Letters 2014; 21 (1) . https://dx.doi.org/10.2174/09298665113209990068
DOI https://dx.doi.org/10.2174/09298665113209990068 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Intranasal Lipid Particulate Drug Delivery Systems: An Update on Clinical Challenges and Biodistribution Studies of Cerebroactive Drugs in Alzheimer’s disease
Current Pharmaceutical Design Editorial (Thematic Issue: Neurology and Genetics: How Molecular Biology is Changing the Neurological Thoughts?)
Current Molecular Medicine Fenofibrate, Homocysteine and Renal Function
Current Vascular Pharmacology ULK1 Plays a Critical Role in AMPK-Mediated Myocardial Autophagy and Contractile Dysfunction following Acute Alcohol Challenge
Current Pharmaceutical Design Cholinesterase Inhibitors: From Weapons, to Pesticides, to Cognition Enhancing Drugs
Current Enzyme Inhibition Patent Review on Laser Interference Lithography Technique for Producing Periodic Nanostructure
Recent Patents on Nanotechnology Mechanisms of Neuropathic Pain
Current Medicinal Chemistry - Central Nervous System Agents Biology of Subjective Cognitive Complaint Amongst Geriatric Patients: Vitamin D Involvement
Current Alzheimer Research Exploring Protein-Protein and Protein-Ligand Interactions in the Immune System using Molecular Dynamics and Continuum Electrostatics
Current Physical Chemistry Alzheimers Disease and Neural Transplantation as Prospective Cell Therapy
Current Alzheimer Research A Review on the Monoacylglycerol Lipase: At the Interface Between Fat and Endocannabinoid Signalling
Current Medicinal Chemistry Editorial [Hot Topic: Pharmacotherapies for the Treatment of Alcohol Abuse and Dependence (Guest Editors: Feng C. Zhou and Richard L. Bell)]
Recent Patents on CNS Drug Discovery (Discontinued) Drug-Drug Interactions: Antiretroviral Drugs and Recreational Drugs
Recent Patents on CNS Drug Discovery (Discontinued) Psychosocial Risk Factors Related to Ischemic Heart Disease in Women
Current Pharmaceutical Design Clinical and Forensic Signs Related to Opioids Abuse
Current Drug Abuse Reviews Recent Advances Toward Improving the Bioavailability of Neuronal Nitric Oxide Synthase Inhibitors
Current Topics in Medicinal Chemistry Subtype-Selective Dopamine Receptor Radioligands for PET Imaging: Current Status and Recent Developments
Current Medicinal Chemistry Depression as is Seen by Molecular Spectroscopy. Phospholipid- Protein Balance in Affective Disorders and Dementia
Current Molecular Medicine Fetuin-A: A Multifunctional Protein
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Editorial [ Production and Fate of Amyloid Peptides: Recent Advances and Perspectives ]
Current Alzheimer Research